Work

Long-term disease control of ≥2 years achieved with cabozantinib in subjects with metastatic medullary thyroid carcinoma on a phase I study.

Year: 2013

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2013.31.15_suppl.6090

Authors: Ezra E.W. Cohen, David S. Hong, David G. Pfister, Ravi Salgia, Barbara Burtness, Roger B. Cohen, Douglas Wilmot Ball, Ranee Mehra, Milan Mangeshkar, Yifah Yaron, Frauke Bentzien, Razelle Kurzrock

Institutions: University of Chicago, The University of Texas MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, Fox Chase Cancer Center, Johns Hopkins University, Exelixis (United States), University of California San Diego

Language: English

Topic: Thyroid Cancer Diagnosis and Treatment

Subfield: Endocrinology, Diabetes and Metabolism

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2598079140

Cites:

Cited by: 1

Related to: 10